Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 130,238 | 141,666 | 197,901 | 161,843 | 150,425 |
| Receivables | 73,726 | 96,043 | 26,703 | 57,237 | 63,450 |
| Inventories | 22,148 | 15,161 | 18,245 | 16,008 | 17,319 |
| Income taxes - deferred | 1,264 | 1,264 | 327 | 638 | 441 |
| TOTAL | $237,079 | $263,347 | $252,935 | $243,215 | $239,542 |
| Non-Current Assets | |||||
| PPE Net | 242,344 | 241,764 | 232,310 | 224,894 | 218,749 |
| Intangibles | 5,502 | 5,502 | 5,502 | 5,502 | 5,502 |
| Other Non-Current Assets | 53,460 | 53,617 | 49,278 | 53,529 | 50,894 |
| TOTAL | $301,306 | $300,883 | $287,090 | $283,925 | $275,145 |
| Total Assets | $538,385 | $564,230 | $540,025 | $527,140 | $514,687 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,470 | 4,470 | 4,148 | 4,057 | 3,280 |
| Accounts payable and accrued liabilities | 23,871 | 31,297 | 27,348 | 23,301 | 28,316 |
| Accrued Expenses | 13,192 | 24,214 | 17,502 | 15,603 | 11,116 |
| TOTAL | $43,541 | $61,907 | $50,572 | $44,465 | $42,995 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57,187 | 58,304 | 58,866 | 58,140 | 57,592 |
| Deferred Revenues | 2,008 | 1,811 | 1,574 | 1,504 | 283 |
| Other Non-Current Liabilities | 2,595 | 2,996 | 3,172 | 4,099 | 3,198 |
| TOTAL | $59,039 | $60,195 | $61,041 | $60,153 | $59,597 |
| Total Liabilities | $102,580 | $122,102 | $111,613 | $104,618 | $102,592 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,121 | 35,926 | 35,851 | 36,204 | 36,161 |
| Common Shares | 36 | 36 | 36 | 36 | 36 |
| Retained earnings | 212,330 | 220,393 | 204,286 | 197,670 | 190,041 |
| Other shareholders' equity | -3,448 | -3,265 | -2,990 | -415 | -728 |
| TOTAL | $435,805 | $442,128 | $428,412 | $422,522 | $412,095 |
| Total Liabilities And Equity | $538,385 | $564,230 | $540,025 | $527,140 | $514,687 |